Unexpectedly, myofibroblast transdifferentiation was not the major cause of the initial Epo loss during a unilateral model of renal tissue remodelling as observed during CKD, and roxadustat efficiently restored Epo expression in the silenced REP cells of the diseased kidney. Here, EPO is linked to chronic kidney disease.